Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Missing a scheduled enzyme replacement therapy (ERT) infusion is common, and the usual guidance is to contact your infusion center or specialist right away to reschedule rather than skipping the dose or doubling the next one. Timing matters because ERT depends on a steady weekly or biweekly rhythm, and longer gaps can allow fatigue, pain, breathing difficulty, or swelling to creep back. Several factors change the safest next step, including your specific diagnosis, how long the delay has lasted, and whether you have had prior infusion reactions, so see below to understand more before you act.
If new or worsening symptoms have appeared while you wait for your rescheduled infusion, it helps to know whether they point to your underlying condition, a delayed dose, or something unrelated that needs separate attention. Take a free, instant, online symptom check to organize what you are feeling and walk into your next call with your care team ready to describe it clearly.
Last reviewed for medical accuracy: 08/18/2026
Enzyme replacement therapy (ERT) with asfotase alfa is a life-changing treatment for hypophosphatasia. Sticking to your prescribed schedule helps maintain bone health, reduce pain, and improve mobility. Yet life happens, and you may occasionally miss a dose. This guide explains exactly what to do if you miss a scheduled asfotase alfa injection, without causing unnecessary worry. It draws on official prescribing information and expert recommendations.
Although individual recommendations may vary slightly by country or clinical situation, most guidelines agree:
Follow these steps if you miss an asfotase alfa injection:
Less than 12 hours late
More than 12 hours late
Very close to your next dose time
Multiple missed doses
Travel or supply issues
Missing a single dose rarely causes a medical emergency, but be alert for:
If any symptoms worsen or new, concerning signs appear, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Reach out immediately if you experience:
Always discuss missed doses at your next appointment. Your doctor may need to adjust your monitoring plan or dosing schedule.
While minor delays can be handled at home, never ignore life-threatening signs. If you suspect severe complications, seek medical care without delay.
Speak to a doctor about anything that could be life-threatening or serious. Proper medical evaluation and guidance are crucial.
Staying informed and prepared can make all the difference in managing your ERT. By following this protocol, you’ll minimize disruptions and continue to get the most out of your asfotase alfa therapy. Remember, no guide replaces personal medical advice—always check with your healthcare team for recommendations tailored to your situation.
(References)
* Hargrove JT, Eisenberg E. Menopause. Med Clin North Am. 1995 Nov;79(6):1337-56. doi: 10.1016/s0025-7125(16)30005-0. PMID: 7475494.
* Johnson SR. Should older women use estrogen replacement? J Am Geriatr Soc. 1996 Jan;44(1):89-90. doi: 10.1111/j.1532-5415.1996.tb05644.x. PMID: 8537598.
* Hartmann BW, Huber JC. The mythology of hormone replacement therapy. Br J Obstet Gynaecol. 1997 Feb;104(2):163-8. doi: 10.1111/j.1471-0528.1997.tb11038.x. PMID: 9070132.
* Rousseau ME. Hormone replacement therapy. Nurse Pract Forum. 1998 Sep;9(3):147-53. PMID: 9782898.
* Salmi T. [Menopausal hormone replacement therapy and quality of life]. Duodecim. 1996;112(12):1035-6. PMID: 10593002.
* Sturdee DW. Continuous combined hormone replacement therapy and its effects. Hosp Med. 1999 Aug;60(8):584-7. doi: 10.12968/hosp.1999.60.8.1180. PMID: 10621815.
* Kenemans P. Menopause, HRT and menopausal symptoms. J Epidemiol Biostat. 1999;4(3):141-6; discussion 146-53. PMID: 10695956.
* Al-Azzawi F. The menopause and its treatment in perspective. Postgrad Med J. 2001 May;77(907):292-304. doi: 10.1136/pmj.77.907.292. PMID: 11320271; PMCID: PMC1742046.
* Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SA, Black HR, Blanchette P, Bonds DE, Brunner RL, Brzyski RG, Caan B, Cauley JA, Chlebowski RT, Cummings SR, Granek I, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Johnson KC, Judd H, Kotchen JM, Kuller LH, Langer RD, Lasser NL, Limacher MC, Ludlam S, Manson JE, Margolis KL, McGowan J, Ockene JK, O'Sullivan MJ, Phillips L, Prentice RL, Sarto GE, Stefanick ML, Van Horn L, Wactawski-Wende J, Whitlock E, Anderson GL, Assaf AR, Barad D, Women's Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006 Feb 16;354(7):669-83. doi: 10.1056/NEJMoa055218. PMID: 16481635.
* Sramek JJ, Murphy MF, Cutler NR. Sex differences in the psychopharmacological treatment of depression. Dialogues Clin Neurosci. 2016 Dec;18(4):447-457. doi: 10.31887/DCNS.2016.18.4/ncutler. PMID: 28179816; PMCID: PMC5286730.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.